These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31140698)

  • 1. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.
    Villa A; Celentano A; Glurich I; Borgnakke WS; Jensen SB; Peterson DE; Delli K; Ojeda D; Vissink A; Farah CS
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):64-78. PubMed ID: 31140698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies.
    Celentano A; Glurich I; Borgnakke WS; Farah CS
    Oral Dis; 2021 May; 27(4):848-880. PubMed ID: 32306449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
    Warnakulasuriya S; Ariyawardana A
    J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review.
    Monteiro L; Mello FW; Warnakulasuriya S
    Oral Dis; 2021 Nov; 27(8):1977-1992. PubMed ID: 33290585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular risk markers for malignant transformation of oral mucosal leukoplakia ].
    Skorodumova LO; Muriaev AA; Volodina EV; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(3):327-32. PubMed ID: 22888646
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature.
    Abadie WM; Partington EJ; Fowler CB; Schmalbach CE
    Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked variation in malignant transformation rates of oral leukoplakia.
    Anderson A; Ishak N
    Evid Based Dent; 2015 Dec; 16(4):102-3. PubMed ID: 26680515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
    Rintala M; Vahlberg T; Salo T; Rautava J
    Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
    Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
    Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients.
    Hogewind WF; van der Kwast WA; van der Waal I
    J Craniomaxillofac Surg; 1989 Apr; 17(3):128-33. PubMed ID: 2651483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Gorecki P; Neukam FW; Strassburg LH; Nkenke E
    Cancer Invest; 2012 Aug; 30(7):495-502. PubMed ID: 22646284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.